Hostname: page-component-745bb68f8f-hvd4g Total loading time: 0 Render date: 2025-01-22T10:44:10.979Z Has data issue: false hasContentIssue false
  • English
  • Français

Neisseria meningitidis

Published online by Cambridge University Press:  02 January 2015

David S. Stephens
David S. Stephens*
Affiliation:
Division of Infectious Diseases, Department of Medicine, VA Medical Center and Emory University School of Medicine, Atlanta, Georgia
Get access Rights & Permissions [Opens in a new window]

Extract

Neisseria meningitidis is an exclusive human pathogen. The organism was first recognized by Weichselbaum in 1887 in the spinal fluid of six patients with acute cerebrospinal meningitis. He called it Diplococcus intracellularis meningitidis because of the presence of the organism within leukocytes from the spinal fluid. Subsequent studies established the meningococcus as the cause of epidemic cerebrospinal fever and placed the organism in the genus Neisseria. Despite the availability of effective antimicrobials and partially effective vaccines, N. meningitidis remains one of the most frequent causes of rapidly fatal sepsis and meningitis.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 6 , Issue 1 , January 1985 , pp. 37 - 40
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1985 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Weichselbaum, A: Ueber die aetiologie der akuten meningitis cerebrospinalis. Fortschr Med 1887; 5:573–583.Google Scholar
2. Councilman, WT, Mallory, FB, Wright, JH: Epidemic cerebrospinal meningitis and its relation to other forms of meningitis. Report of the State Board of Health of Massachusetts, 1898, pp 1–178.Google Scholar
3. Wollstein, M: Biological relationships of Diplococcus intracellulars and gonococcus. J Exp Med 1907; 9:588–605.10.1084/jem.9.5.588Google Scholar
4. Morrello, JA, Bohnhoff, M: Neisseria and Branhamella , in Lennette, EH, Balows, A, Hausler, WJ Jr, et al (eds): Manual of Clinical Microbiology. Washington, American Society for Microbiology, 1980, pp 111–130.Google Scholar
5. Granato, PA, Howard, R, Wilkinson, B, et al: Meningitis caused by maltose-negative variant of Neisseria meningitidis . J Clin Microbiol 1980; 11:270–273.10.1128/jcm.11.3.270-273.1980Google Scholar
6. Kingsbury, DT: Relationship between sulfadiazine resistance and the failure to ferment maltose in Neisseria meningitidis . J Bacterial 1967; 94:557–561.10.1128/jb.94.3.557-561.1967Google Scholar
7. Martin, JE, Armstrong, JH, Smith, PB: New system for cultivation of Neisseria gonorrhoeae . Appl Environ Microbiol 1974; 27:802–805.10.1128/am.27.4.802-805.1974Google Scholar
8. Hoeffler, DF: Recovery of Neisseria meningitidis from the nasopharynx. Comparison of two techniques. Am J Dis Child 1974; 128:54–56.10.1001/archpedi.1974.02110260056009Google Scholar
9. Gotschlich, EC: Development of polysaccharide vaccines for the prevention of meningococcal diseases. Monogr Allergy 1975; 9:245–258.Google Scholar
10. Hermodson, MA, Chen, KCS, Buchanan, TM: Neisseria pili proteins: Aminoterminal amino acid sequences and identification of an unusual amino acid. Biochem J 1978; 17:442–445.10.1021/bi00596a010Google Scholar
11. Craven, DE, Frasch, CE: Pili-mediated and -nonmediated adherence of Neisseria meningitidis and its relationship to invasive disease, in Brooks, GF, Gotschlich, EC, Holmes, KK, et al (eds): Immunobiology of Neisseria gonorrhoeae. Washington, American Society for Microbiology, 1978, pp 250–252.Google Scholar
12. Stephens, DS, McGee, ZA: Attachment of Neisseria meningitidis to human mucosal surfaces: Influence of pili and type of receptor cell. J Infect Dis 1981; 143:525–532.10.1093/infdis/143.4.525Google Scholar
13. DeVoe, IW, Gilchrist, JE: Release of endotoxin in the form of cell wall blebsduringin vitro growth oiNeisseria meningitidis . J Exp Med 1973; 138:1156–1167.10.1084/jem.138.5.1156Google Scholar
14. Tsai, CM, Frasch, CE, Mocea, LF: Five structural classes of major outer membrane proteins in Neisseria meningitidis . J Bacteriol 1981; 146:69–78.10.1128/jb.146.1.69-78.1981Google Scholar
15. DeVoe, IW: The meningococcus and mechanisms of pathogenicity. Microbiol Rev 1982; 46:162–190.10.1128/mr.46.2.162-190.1982Google Scholar
16. Jennings, HJ, Bhattacharjee, AK, Kenne, L: The R-type lipopolysaccharides of Neisseria meningitidis . Can J Biochem 1980; 58:128–136.10.1139/o80-018Google Scholar
17. Lapeyssonnie, L: La meningite cerebro-spinale en Afrique. Supp Bull WHO 1963; 28:3–114.Google Scholar
18. Centers for Disease Control: Meningococcal infections. MMWR 1982; 30:58–61.Google Scholar
19. The Meningococcal Disease Surveillance Group: Analysis of endemic meningococcal disease by serogroup and evaluation of chemoprophylaxis. J Infect Dis 1976; 134:201–204.10.1093/infdis/134.2.201Google Scholar
20. Greenwood, BM, Wali, SS: Control of meningococcal infection in the African meningitis belt by selective vaccination. Lancet 1980; 1:729–732.10.1016/S0140-6736(80)91230-1Google Scholar
21. Frasch, CE, Peppler, MS, Cate, TR, et al: Immunogenicity and clinical evaluation of group B Neisseria meningitidis outer membrane protein vaccines. Seminars in Infectious Diseases 1982; 4:263–267.Google Scholar
22. Kaiser, AB, Hennekens, CH, Saslaw, MS, et al: Seroepidemiology and chemoprophylaxis of disease due to sulfonamide-resistant Neisseria meningitidis in a civilian population. J Infect Dis 1974; 130:217–224.10.1093/infdis/130.3.217Google Scholar
23. Munford, RS, de E Taunay, A, de Morais, JS, et al: Spread of meningococcal infection within households. Lancet 1974; 1:1275–1278.10.1016/S0140-6736(74)90022-1Google Scholar
24. Frasch, CE, Mocea, LF: Strains of Neisseria meningitidis isolated from patients and their close contacts. Infect Immun 1982; 37:155–159.10.1128/iai.37.1.155-159.1982Google Scholar
25. Centers for Disease Control: Nosocomial transmission of group Y Neisseria meningitidis in cancer patients—Connecticut. MMWR 1978; 27:147–153.Google Scholar
26. Tiejesma, RH, te Pas, BJ, de Graaf, P: Isolation and characterization of group H, I, and K meningococcal polysaccharides. Read before the Fifth International Conference on Cerebrospinal Meningitis, Marseilles, France, 1983.Google Scholar
27. Frasch, CE: Role of lipopolysaccharide in wheat germ agglutinin-mediated agglutination of Neisseria meningitidis and Neisseria gonorrhoeae . J Clin Microbiol 1980; 12:498–501.10.1128/jcm.12.4.498-501.1980Google Scholar
28. Slaterus, KW: Serological typing of meningococci by means of microprecipitation. Antonie Van Leeuwenhoek 1961; 27:305–309.10.1007/BF02538460Google Scholar
29. Galaid, EI, Cherubin, CE, Marr, JS, et al: Meningococcal disease in New York City, 1973 to 1978. Recognition of Groups Y and W-135 as frequent pathogens. JAMA 1980; 244:2167–2171.10.1001/jama.1980.03310190019013Google Scholar
30. Hoppes, GM, Ellenbogen, C, Gebhart, RJ: Group Y meningococcal disease in United States Air Force recruits. Am J Med 1977; 62:661–666.Google Scholar
31. Frasch, CE: Noncapsular surface antigens of Neisseria meningitidis , in Weinstein, L, Fields, BN (eds): Seminars in Infectious Diseases. New York, Stratton Intercontinental Medical Book Corp, 1979, vol 2, pp 304–337.Google Scholar
32. Greenfield, S, Sheehe, PR, Feldman, HA: Meningococcal carriage in a population of “normal” families. J Infect Dis 1971; 123:67–73.10.1093/infdis/123.1.67Google Scholar
33. Gordon, MH: Cerebrospinal fever. Studies in the bacteriology, preventive control and specific treatment of cerebrospinal fever among the military forces, 1915-1919. Section 19. The prevalence and distribution of individual types of meningococcus, in Special Report Series 50. London, Medical Research Council of the Privy Council, 1920, p 130.Google Scholar
34. Murray, EGD: The meningococcus, in Special Report Series 124. London, Medical Research Council of the Privy Council, 1928, p 118.Google Scholar
35. Cheever, FS: The control of meningococcal meningitis by mass chemoprophylaxis with sulfadiazine. Am J Med Sci 1945; 209:74–75.10.1097/00000441-194501000-00013Google Scholar
36. Kuns, DM, Nelson, CT, Feldman, HA, et al: The prophylactic value of sulfadiazine in the control of meningococcic meningitis. JAMA 1943; 123:335–339.10.1001/jama.1943.02840410017006Google Scholar
37. Mulks, MH, Plaut, AG, Feldman, HA, et al: IgA protease of two distinct specificities are released by Neisseria meningitidis . J Exp Med 1980; 152:1442–1447.10.1084/jem.152.5.1442Google Scholar
38. Salit, IE, Morton, G: Adherence of Neisseria meningitidis to human epithelial cells. Infect Immun 1981; 31:430–435.10.1128/iai.31.1.430-435.1981Google Scholar
39. Goldschneider, J, Gotschlich, EC, Artenstein, MS: Human immunity to the meningococcus. II. Development of natural immunity. J Exp Med 1969; 129:1327–1348.10.1084/jem.129.6.1327Google Scholar
40. Gold, R, Goldschneider, I, Lepow, ML, et al: Carriage of Neisseria meningitidis and Neisseria lactamica in infants and children. JInfect Dis 1978; 137:112–121.10.1093/infdis/137.2.112Google Scholar
41. Glode, MP, Robbins, JB, Liu, T, et al: Cross-antigenicity and immunogenicity between capsular polysaccharide of group C Neisseria meningitidis and Escherichia coli K92 . J Infect Dis 1977; 135:94–102.10.1093/infdis/135.1.94Google Scholar
42. Janda, WM, Bohnhoff, M, Morello, JA, et al: Prevalence and site-pathogen studies of Neisseria meningitidis and N. gonorrhoeae in homosexual men . JAMA 1980; 244:2060–2064.10.1001/jama.1980.03310180026026Google Scholar
43. Judson, FN, Ehret, JM, Eickhoff, TC: Anogenital infection with Neisseria meningitidis in homosexual men. J Infect Dis 1978; 137:458–463.10.1093/infdis/137.4.458Google Scholar
44. Karolus, JJ, Gandelman, AL, Nolan, BA: Urethritis caused by Neisseria meningitidis . J Clin Microbiol 1980; 12:284–285.10.1128/jcm.12.2.284-285.1980Google Scholar
45. William, DC, Felman, YM, Corsaro, MC: Neisseria meningitidis: Probable pathogens in two related cases of urethritis, epididymitis and acute pelvic inflammatory disease. JAMA 1979; 242:1653–1655.10.1001/jama.1979.03300150051030Google Scholar
46. Stephens, DS, Hoffman, LH, McGee, ZA: Interaction of Neisseria meningitidis with human nasopharyngeal mucosa: Attachment and entry into columnar epithelial cells. J Infect Dis 1983; 148:369–375.10.1093/infdis/148.3.369Google Scholar
47. Mickelsen, PA, Sparling, PF: Ability of Neisseria gonorrhoeae, Neisseria meningitidis and commensal Niesseria species to obtain iron from transferrin and iron compounds. Infect Immun 1981; 33:555–564.10.1128/iai.33.2.555-564.1981Google Scholar
48. Gotschlich, EC: Unresolved problems in the prevention of meningococcal meningitis, in Beers, RF, Bassett, FG (eds): The Role of Immunological Factors in Infections, Allergy and Autoimmune Processes. New York, Raven Press, 1976, pp 91–101.Google Scholar
49. Matthews, N, Stark, JM, Harper, PS, et al: Recurrent meningococcal infections associated with a functional deficiency of the C8 component of human complement. Clin Exp Immunol 1980; 39:53–59.Google Scholar
50. Griffiss, JM, Bertram, MA: Immunoepidemiology of meningococcal disease in military recruits. II. Blocking of serum bactericidal activity by circulating IgA early in the course of invasive disease. J Infect Dis 1977; 136:733–739.10.1093/infdis/136.6.733Google Scholar
51. Gould, JR, Nitz, RE, Hunter, DH, et al: Epidemiology of meningococcal meningitis at Fort Ord. Am J Epidemiol 1965; 82:56–72.10.1093/oxfordjournals.aje.a120532Google Scholar
52. Deal, WB, Sanders, E: Efficacy of rifampin in treatment of meningococcal carriers. N Engl J Med 1969; 281:641–645.10.1056/NEJM196909182811203Google Scholar
53. Scribner, RK, Wedro, BC, Weber, AH, et al: Activities of eight new beta-lactam antibiotics and seven antibiotic combinations against Neisseria meningitidis . Antimicrob Agents Chemother 1982; 21:678–680.10.1128/AAC.21.4.678Google Scholar
54. Cherubin, CE, Corrado, ML, Nair, SR, et al: Treatment of gramnegative bacillary meningitis: Role of new cephalosporin antibiotics. Rev Infect Dis 1982; 4:5453–5464.10.1093/clinids/4.Supplement_2.S453Google Scholar
55. Steele, RW, Bradsher, RW: Ceftriaxone therapy of meningitis and serious infections in children and neonates. Clinical Research 1982; 30:896A.Google Scholar
56. Vershueren, H, Dekegel, M, Dekegel, D, et al: Plasmids in Neisseria meningitidis . Lancet 1982; 1:851–852.10.1016/S0140-6736(82)91896-7Google Scholar
57. Dillon, JR, Pauze, M, Yeung, K-H: Spread of penicillinase-producing and transfer plasmids from the gonococcus to Neisseria meningitidis . Lancet 1983; 1:779–781.10.1016/S0140-6736(83)91846-9Google Scholar